New cancer drugs, China give AstraZeneca welcome sales boost
February 14, 2019 at 02:38 AM EST
AstraZeneca forecast a second straight year of sales growth on Thursday, driven by cancer medicines and other new drugs as the British drugmaker recovers from losing major patents.
